Warning
: your browser is no longer supported.
CLICK HERE
to review the supported browser list.
CLICK HERE
to download a PDF version of this report to read and/or print.
Menu
Close
2023 Annual Report
Letter to Chemours Stakeholders
Form 10-K: Part I
Table of Contents
Explanatory Note
Forward-looking Statements
1. Business
1A. Risk Factors
1B. Unresolved Staff Comments
1C. Cybersecurity
2. Properties
3. Legal Proceedings
4. Mine Safety Disclosures
Information About Our Executive Officers
Part II
5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
6. [Reserved]
7. Management's Discussion and Analysis of Financial Condition and Results of Operations
7A. Quantitative and Qualitative Disclosures About Market Risk
8. Financial Statements and Supplementary Data
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
9A. Controls and Procedures
9B. Other Information
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Part III
10. Directors, Executive Officers, and Corporate Governance
11. Executive Compensation
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
13. Certain Relationships and Related Transactions, and Director Independence
14. Principal Accounting Fees and Services
Part IV
15. Exhibits and Financial Statement Schedules
16. Form 10-K Summary
Signatures
Index to the Consolidated Financial Statements
- Report of Independent Registered Public Accounting Firm
- Consolidated Statements of Operations
- Consolidated Statements of Comprehensive (Loss) Income
- Consolidated Balance Sheets
- Consolidated Statements of Stockholders' Equity
- Consolidated Statements of Cash Flows
- Notes to the Consolidated Financial Statements
Corporate Information
Board of Directors
Chemours Leadership Team
Shareholder Information
Help & Features
Download PDF
Downloads
Company Home
Share
Print
Clickable Index
Thumbnails
Accessibility Features
Help
Menu
Zoom In
Zoom Out
Zoom In
Search
Search
Search
Home
Home
Home
Home
Home
Zoom Out
2023 Annual Report
The Chemours Company
2023 Annual Report
2024 Proxy Statement
2024 Proxy Statement Supplement
{doc4_shortdoctitlestripped}
{doc5_shortdoctitlestripped}
{doc6_shortdoctitlestripped}
{doc7_shortdoctitlestripped}
{doc8_shortdoctitlestripped}
{doc9_shortdoctitlestripped}
{doc10_shortdoctitlestripped}
{doc11_shortdoctitlestripped}
{doc12_shortdoctitlestripped}
{doc13_shortdoctitlestripped}
{doc14_shortdoctitlestripped}
{doc15_shortdoctitlestripped}
Home
Home
Home
Home
Print
Print
Print
Clickable Index
Clickable Index
Thumbnails
Thumbnails
Help
Help
Unpin Menu Bar
Pin Menu Bar
Go to previous page
Go to previous page
Go to previous page
Go to previous page
Go to next page
Go to next page
Go to next page
Page 87 of 181
2023 Annual Report
Letter to Chemours Stakeholders
Form 10-K: Part I
Table of Contents
Explanatory Note
Forward-looking Statements
1. Business
1A. Risk Factors
1B. Unresolved Staff Comments
1C. Cybersecurity
2. Properties
3. Legal Proceedings
4. Mine Safety Disclosures
Information About Our Executive Officers
Part II
5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
6. [Reserved]
7. Management's Discussion and Analysis of Financial Condition and Results of Operations
7A. Quantitative and Qualitative Disclosures About Market Risk
8. Financial Statements and Supplementary Data
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
9A. Controls and Procedures
9B. Other Information
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Part III
10. Directors, Executive Officers, and Corporate Governance
11. Executive Compensation
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
13. Certain Relationships and Related Transactions, and Director Independence
14. Principal Accounting Fees and Services
Part IV
15. Exhibits and Financial Statement Schedules
16. Form 10-K Summary
Signatures
Index to the Consolidated Financial Statements
- Report of Independent Registered Public Accounting Firm
- Consolidated Statements of Operations
- Consolidated Statements of Comprehensive (Loss) Income
- Consolidated Balance Sheets
- Consolidated Statements of Stockholders' Equity
- Consolidated Statements of Cash Flows
- Notes to the Consolidated Financial Statements
Corporate Information
Board of Directors
Chemours Leadership Team
Shareholder Information
2023 Annual Report
2023 Annual Report
Letter to Chemours Stakeholders
Form 10-K: Part I
Form 10-K: Part I
Table of Contents
Explanatory Note
Forward-looking Statements
1. Business
1A. Risk Factors
1B. Unresolved Staff Comments
1C. Cybersecurity
2. Properties
3. Legal Proceedings
4. Mine Safety Disclosures
Information About Our Executive Officers
Part II
Part II
5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
6. [Reserved]
7. Management's Discussion and Analysis of Financial Condition and Results of Operations
7A. Quantitative and Qualitative Disclosures About Market Risk
8. Financial Statements and Supplementary Data
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
9A. Controls and Procedures
9B. Other Information
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Part III
Part III
10. Directors, Executive Officers, and Corporate Governance
11. Executive Compensation
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
13. Certain Relationships and Related Transactions, and Director Independence
14. Principal Accounting Fees and Services
Part IV
Part IV
15. Exhibits and Financial Statement Schedules
16. Form 10-K Summary
Signatures
Index to the Consolidated Financial Statements
- Report of Independent Registered Public Accounting Firm
- Consolidated Statements of Operations
- Consolidated Statements of Comprehensive (Loss) Income
- Consolidated Balance Sheets
- Consolidated Statements of Stockholders' Equity
- Consolidated Statements of Cash Flows
- Notes to the Consolidated Financial Statements
Corporate Information
Corporate Information
Board of Directors
Chemours Leadership Team
Shareholder Information
Single Page View
Double Page View
...Previous
Continue...
WARNING: JavaScript is disabled.
CLICK HERE
for help.
Click here
for a list of supported browsers.
